News from Zyme and the companies we work with.
Tozaro appoints Dr. Jason Slingsby MBA as CEO to lead company strategy in cell and gene therapy sector
Established biotech leader with over 20 years’ experience including at OXB and LifeArc driving commercialization to support CGT downstream manufacturing Michele Pedrocchi PhD appointed as Non-Executive Chair of the Board [...]
Sapio Sciences Introduces Biorepository Management Solution in Sapio Release 25.4
Latest release of Sapio Platform streamlines sample workflows and delivers centralized, compliant biospecimen management Baltimore, MD, 29 April 2025 – Sapio Sciences, the science-aware™ lab informatics platform, today announced Sapio [...]
Metrion Biosciences launches NaV1.9 high-throughput screening assay to strengthen screening portfolio and advance research on new medicines for pain
Validated drug discovery assay overcomes previous challenges in targeting NaV1.9 ion channels for chronic pain signalling Completes unique suite of rapid, scalable pain-related sodium channel assays and services to accelerate [...]
BioSkryb Genomics and Tecan introduce a single-cell multiomics workflow for sequencing-ready libraries in under ten hours
Combines BioSkyrb’s new ResolveOME™ Whole Genome and Transcriptome Single-Cell Core Kit 384-well assay with Uno Single Cell Dispenser™ provided by Tecan in a single workflow Enables scalable, high-throughput analysis of [...]
CN Bio and Pharmaron establish long-term strategic partnership to develop OOC technologies on a global R&D platform
Partnership to validate and promote the application of CN Bio’s PhysioMimix technology, with future opportunities for novel application and assay development Cambridge, UK, 24 April 2025: CN Bio, a leading [...]
Mosaic Therapeutics in-licenses two clinical-stage oncology programs from Astex Pharmaceuticals for development as proprietary combination therapies
In-licensing transforms Mosaic from a research and platform company to a clinical-stage oncology business Mosaic will develop proprietary, targeted combination products, supported by proprietary biomarkers, to realise the full potential [...]
Biodesix partner, Friends of Cancer Research, publishes data in Clinical Cancer Research, demonstrating strong association between ctDNA changes and treatment outcomes for patients with solid tumor types
Aggregate analysis of eight clinical trials of patients with advanced non-small cell lung cancer (aNSCLC) was supported by Biodesix, using Bio-Rad Droplet Digital™ PCR technology LOUISVILLE, CO and HERCULES, Calif. [...]
Mursla Bio Receives FDA Breakthrough Device Designation for EvoLiver Test
Reflects the potential of EvoLiver test to improve early liver cancer detection among high-risk patients EvoLiver leverages Mursla Bio’s platform based on organ-specific extracellular vesicles circulating in blood Breakthrough status [...]
Atelerix signs exclusive agreement with MineBio to establish distribution channel for non-cryogenic cell preservation solutions in China
Partnership with specialist life science distributor establishes sales channel in high-demand market and strengthens global network Hypothermic preservation technology eliminates costs and inefficiencies of cold-chain logistics to enhance biomedical research [...]
Nuclera expands eProtein Discovery capabilities to enable membrane protein production
Membrane proteins synthesized and purified within 48 hours. Active membrane transporter, MsbA and integral membrane protein, ZMPSTE24 synthesized Cambridge, UK, and Boston MA, USA, 14 April 2025: Nuclera, the biotechnology [...]
Source BioScience acquires Cambridge Clinical Laboratories
Acquisition strengthens clinical diagnostics portfolio, providing a complete offering for preclinical and clinical testing services CCL staff and assets to be based in new clinical lab facilities at Source Genomics [...]
Sphere Bio expands APAC distribution network to strengthen presence in region
Operational scale-up accelerates global growth strategy to increase regional access and technical support Cambridge, UK, 9th April 2025: Sphere Bio, a leading provider of picodroplet-based microfluidics for functional single-cell analysis [...]
